Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 77, Issue 1, 2018, Pages 48-54

  Crowson, Cynthia S ^a   Rollefstad, Silvia ^b   Ikdahl, Eirik ^b   Kitas, George D ^c   Van Riel, Piet L C M ^d   Gabriel, Sherine E ^a,e   Matteson, Eric L ^a   Kvien, Tore K ^b   Douglas, Karen ^c   Sandoo, Aamer ^c,f   Arts, Elke ^d   Wållberg Jonsson, Solveig ^g   Innala, Lena ^g   Karpouzas, George ^h   Dessein, Patrick H ^i,j   Tsang, Linda ^j   El Gabalawy, Hani ^k   Hitchon, Carol ^k   Ramos, Virginia Pascual ^l   Yáñez, Irazä Contreras ^l   Sfkakis, Petros P ^m   Zampeli, Evangelia ^m   Gonzalez Gay, Miguel A ⁿ   Corrales, Alfonso ⁿ   Van De Laar, Mart ^o   Vonkeman, Harald E ^o   Meek, Inger ^o   Semb, Anne Grete ^b   more..

^a MAYO CLINIC   (United States)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f BANGOR UNIVERSITY   (United Kingdom)

^g UMEÅ UNIVERSITY   (Sweden)

^h HARBOR UCLA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^k UNIVERSITY OF MANITOBA   (Canada)

^l INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^m UNIVERSITY OF ATHENS   (Greece)

ⁿ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^o MEDISCH SPECTRUM TWENTE   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ANGINA PECTORIS; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DISEASE BURDEN; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; RHEUMATOID ARTHRITIS; RISK REDUCTION; SEX DIFFERENCE; SMOKING; AGED; BLOOD; COMPLICATION; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING;

EID: 85038236789     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-211735     Document Type: Article

References (31)

1. Lindhardsen J, Ahlehoff O, Gislason GH, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011;70:929-34.
2. Gonzalez A, Maradit Kremers H, Crowson CS, et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis 2008;67:64-
3. Solomon DH, Kremer J, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010;69:1920-5.
4. Baghdadi LR, Woodman RJ, Shanahan EM, et al. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 2015;10:e0117952.
5. Crowson CS, Matteson EL, Roger VL, et al. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012;110:420-4.
6. Arts EE, Popa C, Den Broeder AA, et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 2015;74:668-74.
7. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
8. Semb AG, Rollefstad S, Provan SA, et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol 2013;40:359-68.
9. Semb AG, Ikdahl E, Hisdal J, et al. Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases. Int J Cardiol 2016;223:331-6.
10. Corrales A, González-Juanatey C, Peiró ME, et al. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 2014;73:722-7.
11. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011;57:1404-23.
12. Leifheit-Limson EC, Reid KJ, Kasl SV, et al. The role of social support in health status and depressive symptoms after acute myocardial infarction: evidence for a stronger relationship among women. Circ Cardiovasc Qual Outcomes 2010;3:143-50.
13. Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-40.
14. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297-305.
15. Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 2009;68:460-9.
16. Semb AG, Kvien TK, Aastveit AH, et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis 2010;69:1996-2001.
17. Myasoedova E, Crowson CS, Kremers HM, et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010;69:1310-4.
18. Rantapää-Dahlqvist S, Wållberg-Jonsson S, Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:366-8.
19. Peters MJ, Voskuyl AE, Sattar N, et al. The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better. Int J Clin Pract 2010;64:1440-3.
20. Svenson KL, Lithell H, Hällgren R, et al. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med 1987;147:1912-6.
21. Myasoedova E, Crowson CS, Kremers HM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011;70:482-7.
22. Crowson CS, Rollefstad S, Kitas GD, et al. Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS One 2017;12:e0174656.
23. Morris TP, White IR, Royston P, et al. Multiple imputation for an incomplete covariate that is a ratio. Stat Med 2014;33:88-104.
24. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 2004;75:45-9.
25. Crowson CS, Therneau TM, O'Fallon WM. Technical report series No. 82, attributable risk estimation in cohort studies. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA 2009.
26. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001;10:195-216.
27. Schnohr P, Jensen JS, Scharling H, et al. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J 2002;23:620-6.
28. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): casecontrol study. Lancet 2004;364:937-52.
29. Liao KP, Liu J, Lu B, et al. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. Arthritis Rheumatol 2015;67:2004-10.
30. Rauchhaus M, Clark AL, Doehner W, et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003;42:1933-40.
31. Iribarren C, Reed DM, Chen R, et al. Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 1995;92:2396-403.